A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer
Diabetic Foot Ulcer
About this trial
This is an interventional treatment trial for Diabetic Foot Ulcer
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of Type 2 diabetes mellitus
- Clinical diagnosis of Diabetic Foot Ulcer
Exclusion Criteria:
- Type 1 diabetes mellitus(T1DM), special type of diabetes, gestational diabetes mellitus, drug-induced hyperglycemia
- TNTL allergy
- Chronic kidney failure(eGFR≤30ml/min/1.73cm2), severe liver function damage (transaminase ≥ 3 times the normal value), acute or chronic pancreatitis, autoimmune disease, malignant tumors
- Recent acute complications of type 2 diabetes mellitus(ketoacidosis, hyperosmolar nonketotic diabetic coma, lactic acidosis etc.)or other emergency situations
- History of using glucocorticoids and immunosuppressants
- Mental illness and cognitive dysfunction or poor compliance, unable to take medication as required
- Malignant ulcer
Sites / Locations
- Gu YunjuanRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Experimental
Experimental
Standardized Western Medicine Treatment Group
Standardized Western Medicine Treatment +TNTL tablet+TNTL cream Group
Standardized Western Medicine Treatment +TNTL tablet Group
Standardized Western Medicine Treatment +TNTL cream Group
All participants undergo a similar treatment protocol for the diabetic foot, based on the Infectious Diseases Society of America (IDSA).
Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day. Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.
Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day.
Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.